Rajib Paul

Sribhumi, AS 788723, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Potentials of cepharanthine and tomatidine as novel LpxC and TLR4 inhibitors to mitigate gut-mediated inflammation in Parkinson's disease: a high-throughput investigation through molecular docking and dynamic simulation.

Potentials of cepharanthine and tomatidine as novel LpxC and TLR4 inhibitors to mitigate gut-mediated inflammation in Parkinson's disease: a high-throughput investigation through molecular docking and dynamic simulation.

Journal: 3 Biotech

Published: April 09, 2025

Combating Dopaminergic Neurodegeneration in Parkinson's Disease through Nanovesicle Technology.

Combating Dopaminergic Neurodegeneration in Parkinson's Disease through Nanovesicle Technology.

Journal: ACS chemical neuroscience

Published: August 03, 2023

Traversing through the cell signaling pathways of neuroprotection by betanin: therapeutic relevance to Alzheimer's Disease and Parkinson's Disease.

Traversing through the cell signaling pathways of neuroprotection by betanin: therapeutic relevance to Alzheimer's Disease and Parkinson's Disease.

Journal: Metabolic brain disease

Published: August 08, 2022

Assessment of Mitochondrial Complex II and III Activity in Brain Sections: A Histoenzymological Technique.

Assessment of Mitochondrial Complex II and III Activity in Brain Sections: A Histoenzymological Technique.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: June 30, 2022

Garcinia morella extract confers dopaminergic neuroprotection by mitigating mitochondrial dysfunctions and inflammation in mouse model of Parkinson's disease.

Garcinia morella extract confers dopaminergic neuroprotection by mitigating mitochondrial dysfunctions and inflammation in mouse model of Parkinson's disease.

Journal: Metabolic brain disease

Published: February 16, 2022

Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response.

Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response.

Journal: Experimental brain research

Published: October 19, 2020

Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders.

Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders.

Journal: Neurochemistry international

Published: July 31, 2020

Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects.

Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects.

Journal: Life sciences

Published: May 29, 2020

Lycopene - A pleiotropic neuroprotective nutraceutical: Deciphering its therapeutic potentials in broad spectrum neurological disorders.

Lycopene - A pleiotropic neuroprotective nutraceutical: Deciphering its therapeutic potentials in broad spectrum neurological disorders.

Journal: Neurochemistry international

Published: May 22, 2020

Natural Products and Their Therapeutic Effect on Autism Spectrum Disorder.

Natural Products and Their Therapeutic Effect on Autism Spectrum Disorder.

Journal: Advances in neurobiology

Published: February 02, 2020

Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics.

Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics.

Journal: Neurochemistry international

Published: December 24, 2018

Garcinol, a multifaceted sword for the treatment of Parkinson's disease.

Garcinol, a multifaceted sword for the treatment of Parkinson's disease.

Journal: Neurochemistry international

Published: December 18, 2018

Showing 1-12 of 28

Last Updated: 09/26/2026